Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2012
05/03/2012CA2815960A1 Tau imaging probe
05/03/2012CA2815910A1 Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive impairment or alzheimer's disease
05/03/2012CA2815582A1 Treatment of mecp2-associated disorders
05/03/2012CA2815542A1 Use of a spironolactone-based composition that exhibits an inhibitory action on t-lymphocyte activation which is useful for preventing and/or treating multiple sclerosis
05/03/2012CA2815278A1 Immunogenic compositions and methods for treating neurologic disorders
05/03/2012CA2814905A1 Indole derivatives and process for their preparation
05/03/2012CA2808196A1 Peptide compound useful for inhibiting amyloid plaque formation
05/03/2012CA2804797A1 Therapeutic compositions for diabetic symmetrical polyneuropathy and/or tactile allodynia
05/02/2012EP2447265A1 Novel thiophene carboxamide derivative and medicinal use of same
05/02/2012EP2447264A1 N-substituted-cyclic amino derivative
05/02/2012EP2447254A1 Crystals
05/02/2012EP2446883A1 Treatment of inflammation
05/02/2012EP2446881A1 Orally Dissolving Films
05/02/2012EP2446037A2 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
05/02/2012EP2445899A1 Novel fumarate salts of a histamine h3 receptor antagonist
05/02/2012EP2445887A2 Novel azabicyclohexanes
05/02/2012EP2445877A2 Bicyclic compounds and methods of making and using same
05/02/2012EP2445873A2 Protease inhibitors, compositions and methods of use
05/02/2012EP2445531A2 Methods of increasing neuronal differentiation using antibodies to lysophoshatidic acid
05/02/2012EP2445509A1 Zinc supplementation to increase responsiveness to metalloprotease therapy
05/02/2012EP2445504A1 ENANTIOMERIC COMPOSITIONS OF 2-AMINO-1-(2-ISOPROPYLPYRAZOLO[1,5-a]PYRIDIN-3-YL)PROPAN-1-ONE AND RELATED METHODS
05/02/2012EP2445498A1 A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
05/02/2012EP2445496A2 Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis
05/02/2012EP2445489A2 Compositions for treating drug addiction and improving addiction-related behavior
05/02/2012EP2445488A1 Process for obtaining purified pterostilbene and methods of use thereof
05/02/2012EP2238130B1 Carboxamide compounds and their use as calpain inhibitors
05/02/2012EP2217593B1 1,2,4,-triazin-3,5-dione compounds for treating disorders that respond to modulation of the dopamine d3 receptor
05/02/2012EP2039687B1 Therapeutic or prophylactic agent for multiple sclerosis
05/02/2012EP2007724B1 Piperidine derivatives for treatment of alzheimer's disease
05/02/2012EP1934177B1 Prolinamide derivatives as sodium channel modulators
05/02/2012EP1848275B1 Kappa opioid receptor ligands
05/02/2012EP1716851B1 Thioamides and salts thereof and cytokine production inhibitors containing both
05/02/2012EP1693060B1 Therapeutic or preventive agents for ischemic neuropathy
05/02/2012EP1627869B1 Vanilloid receptor modulators
05/02/2012EP1534668B1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
05/02/2012EP1517905B1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
05/02/2012EP1487431B1 Preventing and/or treating cardiovascular disease and/or associated heart failure
05/02/2012EP1429723B1 Treating effects of excessive reactive oxygen species
05/02/2012EP1389130B1 Use of osteopontin for the treatment and/or prevention of neurologic diseases
05/02/2012EP1372682B1 Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic aa amyloidosis, and other amyloid disorders
05/02/2012EP1032403B1 Nutritional supplement for cerebral metabolic insufficiencies
05/02/2012CN102439136A Mesenchymal stem cells producing inhibitory rna for disease modification
05/02/2012CN102439041A Modulation of the vps 10-domain receptor family for the treatment of mental and behavioural disorders
05/02/2012CN102439015A 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
05/02/2012CN102439009A 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
05/02/2012CN102439008A 1,2,3-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
05/02/2012CN102439007A Amide derivative
05/02/2012CN102439005A Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
05/02/2012CN102438992A Method of inducing cleavage of amyloid precursor protein to form a novel fragment
05/02/2012CN102438991A Carbinol compound having heterocyclic linker
05/02/2012CN102438988A Resorcinol derivatives as hsp90 inhibitors
05/02/2012CN102438986A Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
05/02/2012CN102438655A Plant fiber product and method for its manufacture
05/02/2012CN102438622A A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
05/02/2012CN102438614A Pyrone analogs for therapeutic treatment
05/02/2012CN102438607A Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
05/02/2012CN102438587A Compositions for continuous administration of dopa decarboxylase inhibitors
05/02/2012CN102433245A Health-care medicated wine capable of improving memory
05/02/2012CN102432690A Application of Opuntia ficus-indica Milpa Alta polysaccharides to prevention and treatment of chronic neurodegenerative disease
05/02/2012CN102432490A Agomelatine crystal form D and preparation method thereof
05/02/2012CN102432483A Preparation method of acetyl levocarnitine hydrochloride, and drug application of acetyl levocarnitine hydrochloride
05/02/2012CN102430122A Fluoxertine hydrochloride orally disintegrating tablet and preparation method thereof
05/02/2012CN102430117A Modified proteases that inhibit complement activation
05/02/2012CN102430110A CAlprostadil composite medicament of compound fermented cordyceps sinensis powder and alprostadil composite drug
05/02/2012CN102430102A Preparation method for huangqi-guizhi-wuwu granule
05/02/2012CN102430093A Micro-sphere injection capable of resuscitating consciousness and preparation method thereof
05/02/2012CN102430082A Traditional Chinese medicine sachet and preparation method thereof
05/02/2012CN102430070A Traditional Chinese medicament for treating cervical spondylosis
05/02/2012CN102430069A Traditional Chinese medicine for treating delayed epilepsia after cerebral hemorrhage
05/02/2012CN102430060A Cold and hot temperature difference method for processing tall gastrodia tuber
05/02/2012CN102430011A Traditional Chinese medicinal composition for traditional Chinese moxibustion treatment, preparation method and applications thereof
05/02/2012CN102430000A Traditional Chinese medicinal composition for treating Alzheimer-type disease and preparation method thereof
05/02/2012CN102429983A Medicine for treating cold and preparation method thereof
05/02/2012CN102429982A Traditional Chinese medicine granules for treating cold and preparation method thereof
05/02/2012CN102429981A Chinese medicine for treating cold and preparation method thereof
05/02/2012CN102429979A Traditional Chinese medicine composition for treating cold and preparation method thereof
05/02/2012CN102429968A Drug combination for treating insomnia and preparation method thereof
05/02/2012CN102429964A Medicine composition for preventing cognitive disorder of old people after surgical operation
05/02/2012CN102429962A Preparation method of piper laetispicum extractive, extractive and application thereof
05/02/2012CN102429943A Sugar-free erigeron breviscapus mixture and preparation method thereof
05/02/2012CN102429932A Method for extracting lucid ganoderma essence
05/02/2012CN102429931A Compound fermented cordyceps fungus powder salvianic acid combined drug
05/02/2012CN102429930A Compound fermented cordyceps fungus powder and baicalin combined drug,
05/02/2012CN102429929A Compound fermented cordyceps fungus powder and taurine combined drug
05/02/2012CN102429911A Application of ZSTK474 to preparation of medicine for treating autoimmune diseases
05/02/2012CN102429909A Medicine for treating neurodegenerative disease
05/02/2012CN102429908A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
05/02/2012CN102429906A Use of nitrogen heterocyclic compound in preparing drug for inhibiting toxicity of amyloid polypeptide
05/02/2012CN102429905A Medicinal composition containing tetrahydropalmatine and imperatorin
05/02/2012CN102429897A Pharmaceutical composition for improving oral bioavailability of morin
05/02/2012CN102429884A Methylphenidate hydrochloride oral cavity disintegrating pharmaceutical composition
05/02/2012CN102429883A Fluoxetine hydrochloride oral cavity disintegrating pharmaceutical composition
05/02/2012CN102429882A Gabapentin prodrug sustained release oral dosage forms
05/02/2012CN102429873A Desmethylvenlafaxine sustained-release pellet and preparation method thereof
05/02/2012CN102145093B Traditional Chinese medicine composition for treating schizophrenia
05/02/2012CN102028910B Chinese medicinal preparation for treating Alzheimer's disease and preparation method thereof
05/02/2012CN101897738B Application of actinidia kolomicta leaf flavonoids in preparing medicines for preventing and treating vascular dementia
05/02/2012CN101856468B Medicinal composition for treating senile dementia and preparation method thereof
05/02/2012CN101785832B Traditional Chinese medicine preparation and preparation method thereof for skin disease treatment
05/02/2012CN101721690B Application of PTD-SOD fusion protein in anti-intoxication alcohol neutralizing product